Cellectar Biosciences, Inc. (CLRB)
2.34
-0.02
(-0.85%)
USD |
NASDAQ |
Jun 10, 15:16
Cellectar Biosciences EPS Diluted (TTM) : -7.374 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Karyopharm Therapeutics, Inc. | -15.09 |
| Forum Markets, Inc. | -35.46 |
| ACADIA Pharmaceuticals, Inc. | 2.196 |
| Alnylam Pharmaceuticals, Inc. | 4.209 |
| Savara, Inc. | -0.5584 |